TY  - JOUR
AU  - Buendía, I.
AU  - Parada, E.
AU  - Navarro González De Mesa, Elisa
AU  - León Martínez, Rafael
AU  - Negredo Madrigal, Pilar
AU  - Egea Máiquez, Francisco Javier
AU  - García López, Manuela
PY  - 2015
DO  - 10.1007/s12035-015-9272-5
SN  - 0893-7648
SN  - 1559-1182
UR  - https://hdl.handle.net/20.500.14352/93264
T2  - Molecular Neurobiology
AB  - Melatonin is a neurohormone whose levels are significantly reduced or absent in Alzheimer's disease (AD) patients. In these patients, acetylcholinesterase inhibitors (AChEI) are the major drug class used for their treatment; however, they present...
LA  - eng
M2  - 3338
PB  - Springer
KW  - Alzheimer disease
KW  - Combined therapy
KW  - Galantamine
KW  - Inflammation
KW  - Melatonin
KW  - Oxidative stress
TI  - Subthreshold Concentrations of Melatonin and Galantamine Improves Pathological AD-Hallmarks in Hippocampal Organotypic Cultures
TY  - journal article
VL  - 53
ER  -